Dr. Martin Zügel, CEO Merz Pharmaceuticals
Dr. Alexander Gebauer, Research & Development
Dr. Eugen Wilbert, Marketing & Sales Germany, Austria, Switzerland
District Court at Frankfurt am Main, HRB 53808,
USt.Id.-Nr. DE813402170
Merz Pharmaceuticals GmbH
Responsible: Fr. Dr. Susanne Hartmann
E-Mail: Susanne.Hartmann@merz.de
Information on these sites is not intended for U.S. Residents.
![zurück zum Seitenanfang [link]](skin_img/skin_contentSiteInfo-backToTop-arrow.gif)
Last update: 17.02.2011, 15:43
produced by GPM mbH
URL: http://www.dystoniainfo.com/metadata/imprint/
Stand: 17.02.2011, 15:43 Uhr
© 2012 Merz. Alle Rechte vorbehalten.